Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Amoxicillin-d4

Amoxicillin-d4 (Synonyms: Amoxycillin D4)

Catalog No.GC40232

Amoxicillin-d4 is intended for use as an internal standard for the quantification of amoxicillin by GC- or LC-MS.

Products are for research use only. Not for human use. We do not sell to patients.

Amoxicillin-d4 Chemical Structure

Cas No.: 2673270-36-3

Size Price Stock Qty
500μg
$197.00
In stock
1mg
$375.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Amoxicillin-d4 is intended for use as an internal standard for the quantification of amoxicillin by GC- or LC-MS. Amoxicillin is an orally bioavailable, semisynthetic β-lactam antibiotic. It inhibits the growth of 30 isolates of P. mirabilis and 89% of 30 E. coli strains when used at concentrations greater than or equal to 5 and 10 µg/ml, respectively, but resistance develops in strains of Klebsiella, Enterobacter, and indole-positive Proteus species. Amoxicillin is susceptible to bacterial β-lactamases but is active against β-lactamase-producing bacteria when used in combination with β-lactamase antibiotics such as clavulanic acid with MIC values of greater than 4,096 and 16 µg/ml without or with clavulanic acid, respectively, against 46 clinical isolates of β-lactamase-producing E. coli. Formulations containing amoxicillin have been used in the treatment of a variety of bacterial infections.

Reviews

Review for Amoxicillin-d4

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Amoxicillin-d4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.